Gene · 5933
Papers2,741
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,741
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Current updates of CRISPR/Cas9-mediated genome editing and targeting within tumor cells: an innovative strategy of cancer management. | Cancer Commun (Lond) | 2022 | 36209487 | PubTator, text mining | PubMed |
| The role of inner nuclear membrane proteins in tumourigenesis and as potential targets for cancer therapy. | Cancer Metastasis Rev | 2022 | 36205821 | PubTator, text mining | PubMed |
| Anti-cancer properties of Caulerpa racemosa by altering expression of Bcl-2, BAX, cleaved caspase 3 and apoptosis in HeLa cancer cell culture. | Front Oncol | 2022 | 36203436 | PubTator, text mining | PubMed |
| Human papillomavirus-related neoplasia of the ocular adnexa. | Acta Ophthalmol | 2022 | 36203222 | PubTator, text mining | PubMed |
| microRNA-205 in prostate cancer: Overview to clinical translation. | Biochim Biophys Acta Rev Cancer | 2022 | 36191828 | PubTator, text mining | PubMed |
| Serine 13 of the human cytomegalovirus viral cyclin-dependent kinase UL97 is required for regulatory protein 14-3-3 binding and UL97 stability. | J Biol Chem | 2022 | 36150501 | PubTator, text mining | PubMed |
| Do or Die: HPV E5, E6 and E7 in Cell Death Evasion. | Pathogens | 2022 | 36145459 | PubTator, text mining | PubMed |
| Mir-29b in Breast Cancer: A Promising Target for Therapeutic Approaches. | Diagnostics (Basel) | 2022 | 36140539 | PubTator, text mining | PubMed |
| p53: From Fundamental Biology to Clinical Applications in Cancer. | Biology (Basel) | 2022 | 36138802 | PubTator, text mining | PubMed |
| MiR-942-3p as a Potential Prognostic Marker of Gastric Cancer Associated with AR and MAPK/ERK Signaling Pathway. | Curr Issues Mol Biol | 2022 | 36135175 | PubTator, text mining | PubMed |
| Mid-trimester dilated fetal bowel leading to diagnosis of interstitial duplication 46,XX,dup(8)(q21.13q21.2) associated with extensive neonatal jejuno-ileal atresia. | Radiol Case Rep | 2022 | 36132065 | PubTator, text mining | PubMed |
| Landscape of RB1 alterations in 22,432 Chinese solid tumor patients. | Ann Transl Med | 2022 | 36110997 | PubTator, text mining | PubMed |
| WNT5A-RHOA Signaling Is a Driver of Tumorigenesis and Represents a Therapeutically Actionable Vulnerability in Small Cell Lung Cancer. | Cancer Res | 2022 | 36102736 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing Identifies Pathogenic Germline Variants in Patients with Lynch-Like Syndrome. | Cancers (Basel) | 2022 | 36077770 | PubTator, text mining | PubMed |
| A Pan-Cancer Assessment of RB1/TP53 Co-Mutations. | Cancers (Basel) | 2022 | 36077736 | PubTator, text mining | PubMed |
| Regulating the regulator: a survey of mechanisms from transcription to translation controlling expression of mammalian cell cycle kinase Aurora A. | Open Biol | 2022 | 36067794 | PubTator, text mining | PubMed |
| CDK4: a master regulator of the cell cycle and its role in cancer. | Genes Cancer | 2022 | 36051751 | PubTator, text mining | PubMed |
| Z-Guggulsterone Is a Potential Lead Molecule of Dawa-ul-Kurkum against Hepatocellular Carcinoma. | Molecules | 2022 | 36014345 | PubTator, text mining | PubMed |
| Regulation of Embryonic Stem Cell Self-Renewal. | Life (Basel) | 2022 | 36013330 | PubTator, text mining | PubMed |
| The Interaction of Human Papillomavirus Infection and Prostaglandin E2 Signaling in Carcinogenesis: A Focus on Cervical Cancer Therapeutics. | Cells | 2022 | 36010605 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5933/papers?page=12